Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-30

Clinical Trial Update: Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating budesonide rectal foam versus placebo for preventing acute radiation proctitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide Rectal Foam (budesonide)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Radiation Proctitis | Phase 2 | Status: TERMINATED